Skip to main content
Equibles
CHCT logo

CHCT · Community Healthcare Trust Inc · Metrics

Track CHCT — free

Use CHCT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CHCT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$14.61 -0.02 (-0.14%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Market Cap
$418.63M
Shares
28.65M

CHCT metrics

72 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$14.61
Market cap
$418.63M

Price action

20 metrics
Price change (1W)
-2.6%
Price change (30D)
-3.1%
Price change (3M)
-18.4%
Price change (6M)
-9.5%
Price change (YTD)
-11.0%
Price change (1Y)
-7.1%
Trailing year
Price change (5Y)
-68.4%
52-week high
$19.02
52-week low
$13.31
Change from 52-week high
-23.2%
Change from 52-week low
+9.8%
Annualized volatility
27.8%
Annualized volatility (3M)
34.5%
Beta
0.2
RSI (14D)
34.1
Price vs SMA 50
-11.6%
Price vs SMA 200
-13.0%
Avg volume (3M)
297,927
Relative volume
0.8
Average dollar volume
$4.86M

Company

3 metrics
Sector
Real Estate
Industry
REIT - Healthcare Facilities
Shares outstanding
28.65M

Valuation

12 metrics
P / E (TTM)
21.5
Trailing earnings · reciprocal yield 4.7%
PEG ratio
—
EV / revenue
7.8×
reciprocal yield 12.8%
EV / EBITDA
—
EV / EBIT
—
P / sales
3.4×
reciprocal yield 29.8%
P / book
1.0
reciprocal yield 99.0%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
7.0
reciprocal yield 14.2%
Earnings yield
5.0%

Historical valuation

8 metrics
P / E historical average (3Y)
121.1×
reciprocal yield 0.8%
P / E historical average (5Y)
89.5×
reciprocal yield 1.1%
EV / revenue historical average (3Y)
9.1×
reciprocal yield 11.0%
EV / revenue historical average (5Y)
11.0×
reciprocal yield 9.1%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
12.1%
Trailing 12 months
Payout ratio
259.5%
Shareholder yield
13.0%
Dividend / share (TTM)
$1.76
Dividend growth YoY
-6.0%
Dividend growth streak
5
Last ex-dividend
2026-08-19

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
16.8%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
$20.98M
Trailing 12 months
Diluted EPS (TTM)
$0.68
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$15.08

Growth

11 metrics
Revenue growth YoY
+7.4%
Year over year
Net income growth YoY
—
Revenue (TTM)
$124.78M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.8%
Year over year · more shares
Revenue CAGR (3Y)
+7.5%
Revenue CAGR (5Y)
+9.9%
EPS CAGR (3Y)
-53.8%
EPS CAGR (5Y)
-36.9%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
5.1%
Return on assets
2.1%
Debt / equity
1.4
Current ratio
—
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$556.65M
Latest balance sheet
Cash & equivalents
$2.67M
Total assets
$1.00B
Total debt
$559.32M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$59.49M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$10.55M
R&D / revenue
—
Stock compensation / revenue
8.5%

Ownership (13F)

3 metrics
13F filers
171
13F filer change QoQ
+8
Institutional ownership
81.1%

Short interest

3 metrics
Short interest
3.9%
Latest settlement · 2.5 days to cover
Days to cover
2.5d
Short-squeeze score
51 / 100

Insider activity

2 metrics
Net insider buying (90D)
$272,980
Insider-sentiment score
88 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1631569 CUSIP 20369C106 13F (30d) 55 filings 52 filers Visit website Investor relations